AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 193 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $17,473,000 | +118.2% | 292,000 | +2.5% | 3.43% | +18.4% |
Q3 2019 | $8,006,000 | -24.5% | 285,000 | +1.8% | 2.90% | -10.4% |
Q2 2019 | $10,601,000 | -3.0% | 280,000 | 0.0% | 3.23% | +6.8% |
Q1 2019 | $10,926,000 | +105.0% | 280,000 | +12.0% | 3.02% | +52.1% |
Q4 2018 | $5,330,000 | -40.2% | 250,000 | +11.1% | 1.99% | -12.2% |
Q3 2018 | $8,907,000 | +22.7% | 225,000 | +18.4% | 2.27% | +20.6% |
Q2 2018 | $7,259,000 | +27.2% | 190,000 | 0.0% | 1.88% | +15.1% |
Q1 2018 | $5,709,000 | -14.2% | 190,000 | -9.5% | 1.63% | -23.4% |
Q4 2017 | $6,652,000 | +32.0% | 210,000 | +16.7% | 2.13% | +19.5% |
Q3 2017 | $5,041,000 | +75.7% | 180,000 | +20.0% | 1.78% | +48.8% |
Q2 2017 | $2,869,000 | – | 150,000 | – | 1.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |